Sigyn Therapeutics, Inc.
SIGY
Revenue
3.83k
▲3.08k▲407.14%
6 Months ChangeAssets
320.17k
▼-3.13k▼-0.9682%
3 Months ChangeLiabilities
3.99M
▼-352.24k▼-8.11%
3 Months ChangeFree Cash Flow
-277.30k
▼-168.86k▼-155.73%
48 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0001493152-24-041287
2024-10-07
Form 8-K
ID: 0001493152-24-039594
2024-08-19
Form 10-Q
ID: 0001493152-24-033048
2024-06-06
Form 8-K
ID: 0001493152-24-022945
2024-05-15
Form 8-K
ID: 0001493152-24-020007
2024-05-14
Form 10-Q
ID: 0001493152-24-019221
2024-04-16
Form 8-K
ID: 0001493152-24-014866
2024-01-31
Form 8-K
ID: 0001493152-24-004502
2024-01-30
Form 8-K
ID: 0001493152-24-004320
2024-01-11
Form 8-K
ID: 0001493152-24-002048